NCT04912037

Brief Summary

In this study,the AI-assisted system(EndoAngel)has the functions of reminding the ileocecal junction, withdrawal time, withdrawal speed, sliding lens, polyps in the field of vision, etc. These functions can improve the colonoscopy performance of novice physicians and assist the colonoscopy training。

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
385

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jun 2021

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 28, 2021

Completed
4 days until next milestone

Study Start

First participant enrolled

June 1, 2021

Completed
2 days until next milestone

First Posted

Study publicly available on registry

June 3, 2021

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2022

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2022

Completed
Last Updated

June 3, 2021

Status Verified

May 1, 2021

Enrollment Period

7 months

First QC Date

May 28, 2021

Last Update Submit

May 28, 2021

Conditions

Outcome Measures

Primary Outcomes (2)

  • CUSUM learning curve for colonoscopy (ACE scoring scale)

    From the beginning to the end of colonoscopy training

  • Average test score difference before and after training

    From the beginning to the end of colonoscopy training

Secondary Outcomes (14)

  • Detection rate of advanced adenoma

    A month

  • Polyp Detection Rate, PDR

    A month

  • Average number of adenomas detected per patient

    A month

  • The detection rate of large, small and micro polyps

    A month

  • The average number of large, small and micro polyps detected

    A month

  • +9 more secondary outcomes

Study Arms (2)

with AI-assisted system

EXPERIMENTAL

The novice doctors are trained in colonoscopy with an artificial intelligence assisted system that can indicate abnormal lesions and the speed of withdrawal in real time, as well as feedback on the percentage of overspeed.

Device: artificial intelligence assistance system

without AI-assisted system

NO INTERVENTION

The novice doctors receive routine colonoscopy training without artificial intelligence assistance system and no special tips

Interventions

the artificial intelligence assistance system can indicate abnormal lesions and real-time withdrawal speed, and feedback the overspeed percentage.

with AI-assisted system

Eligibility Criteria

Age50 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Male or female ≥50 years old;
  • Able to read, understand and sign informed consent
  • The investigator believes that the subjects can understand the process of the clinical study, are willing and able to complete all study procedures and follow-up visits, and cooperate with the study procedures
  • Patients requiring colonoscopy

You may not qualify if:

  • Have drug or alcohol abuse or mental disorder in the last 5 years
  • Pregnant or lactating women
  • Patients with known multiple polyp syndrome;
  • patients with known inflammatory bowel disease;
  • known intestinal stenosis or space-occupying tumor;
  • known colon obstruction or perforation;
  • patients with a history of colorectal surgery;
  • Patients with previous history of allergy to pre-used spasmolysis;
  • Unable to perform biopsy and polyp removal due to coagulation disorders or oral anticoagulants;
  • High risk diseases or other special conditions that the investigator considers the subject unsuitable for participation in the clinical trial.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Renmin hospital of Wuhan University

Wuhan, Hubei, 430000, China

RECRUITING

MeSH Terms

Conditions

Gastrointestinal Diseases

Condition Hierarchy (Ancestors)

Digestive System Diseases

Study Officials

  • Yu w Honggang, Doctor

    Renmin Hospital of Wuhan University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Yu W Honggang, Doctor

CONTACT

Yu Honggang, Doctor

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
DIAGNOSTIC
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 28, 2021

First Posted

June 3, 2021

Study Start

June 1, 2021

Primary Completion

January 1, 2022

Study Completion

February 1, 2022

Last Updated

June 3, 2021

Record last verified: 2021-05

Locations